4//SEC Filing
Patience David 4
Accession 0001826667-25-000131
CIK 0001826667other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 4:18 PM ET
Size
5.8 KB
Accession
0001826667-25-000131
Insider Transaction Report
Form 4
Patience David
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-08-28+248,899→ 538,899 totalExercise: $5.11→ Common Stock (248,899 underlying)
Footnotes (2)
- [F1]Represents the granting of stock options upon achieving or exceeding $75 million of revenue over any twelve (12) consecutive calendar month period ending on or before December 31, 2027. The options vest immediately upon achieving the performance requirement, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
- [F2]The stock options expire on December 31, 2027 if the revenue threshold is not met.
Documents
Issuer
TriSalus Life Sciences, Inc.
CIK 0001826667
Entity typeother
Related Parties
1- filerCIK 0001970009
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 4:18 PM ET
- Size
- 5.8 KB